InvestorsHub Logo
Followers 13
Posts 1551
Boards Moderated 0
Alias Born 02/06/2019

Re: None

Friday, 05/05/2023 11:06:03 AM

Friday, May 05, 2023 11:06:03 AM

Post# of 2809
Street target price: Avg based on yahoos finance page is $31/sh...

Something to track although they say they have a lot of cash on hand (they should they doubled up the damn share count to 25 Million) is the 'share count' which as of the end of the 1st qtr 2023 is around 25 Million..

So from a timeline standpoint, end of this year for an NDA submission.. add 9 months to that..

If I had shares right now, I would be selling the covered calls for what I could get, at the $10 level. Just don't see a reason coming in the near future to jeopardize $10/sh..

disclaimer: still don't have any, loaded with CRMD which just got their timeline clarified, sitting at $5/sh, target price $15 on 41 Million shares outstanding. And if they get the additional sector (oncology) we know they will be asking approval for, well that puts the target price north around $25+.. Just going to take till the end of the year for an FDA decision from the looks of it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ATNM News